Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
収録刊行物
-
- The Lancet
-
The Lancet 387 (10026), 1405-1414, 2016-04
Elsevier BV